ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients – Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?

BACKGROUND: ABO-incompatible (ABO-i) living donor liver transplantation (LDLT) is a feasible alternative for donor liver allograft in emergency situations, especially in Asia, where deceased-donor organs remain scarce. The reported outcomes of ABO-i LDLT after optimal desensitization are comparable...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transplant
Autors principals: Hsu, Shih-Chao, Thorat, Ashok, Jeng, Long-Bin, Li, Ping-Chun, Yeh, Chun-Chieh, Chen, Te-Hung, Yang, Horng-Ren, Poon, Kin-Shing
Format: Artigo
Idioma:Inglês
Publicat: International Scientific Literature, Inc. 2020
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7526337/
https://ncbi.nlm.nih.gov/pubmed/32943600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/AOT.923502
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars